Table 2.
Reference | Year | LncRNA | Total patients (n) | Survival analysis | Follow-up (months) |
---|---|---|---|---|---|
Wang et al21 | 2017 | TUG1 | 44 | OS | 120 |
Wen et al23 | 2017 | UCA1 | 151 | OS | 60 |
Zhou et al30 | 2017 | CCAL | 46 | OS | 60 |
Chen et al24 | 2016 | BCAR4 | 60 | OS | 60 |
Cong et al32 | 2016 | TUSC7 | 82 | OS | 120 |
Gao and Lian27 | 2016 | MALAT1 | 162 | OS | 65 |
Ju et al25 | 2016 | BCAR4 | 168 | OS | 68 |
Li et al26 | 2016 | HIF2PUT | 82 | OS | 60 |
Li et al22 | 2016 | UCA1 | 135 | OS | 60 |
Ma et al20 | 2016 | TUG1 | 76 | OS | 60 |
Uzan et al33 | 2016 | HULC | 33 | OS | 96 |
Xia et al29 | 2016 | 91H | 67 | OS | 60 |
Zhao et al15 | 2016 | HNF1A-AS1 | 43 | OS | 60 |
Li et al28 | 2015 | HOTTIP | 68 | OS | 60 |
Sun et al17 | 2015 | HULC | 78 | OS | 60 |
Tian et al31 | 2015 | MEG3 | 64 | OS | 60 |
Abbreviations: lncRNA, long noncoding RNA; OS, overall survival.